Kimberly-Clark Corporation Revenue in 2024

Kimberly-Clark Corporation reported $19.5B in revenue for fiscal year 2024. This represents a growth of 1% compared to the 2023 figure of $19.3B.

The single most clarifying financial fact about Kimberly-Clark is that its gross margin in fiscal year 2024 reached 34.2% despite extreme volatility in global fluff pulp and energy prices — the two input costs that most directly threaten a tissue manufacturer's economics. That margin stability is not accidental. It reflects a hedging program and a premium product mix shift toward higher-margin variants that the company has been executing systematically. Net sales held at $19.5 billion in FY2024, matching the $19.5 billion reported in FY2022 and recovering from the $19.3 billion posted in FY2023. The revenue base is not growing quickly, but it is not shrinking either — a pattern consistent with a company operating in mature categories with strong brand positions but limited pricing elasticity. Net income reached $1.5 billion against $19.5 billion in sales, a net margin of approximately 7.7%. The Personal Care segment, which houses Huggies and Depend, generates the highest gross margins in the portfolio at approximately 38%, creating a meaningful mix-benefit when that segment outperforms the tissue business. The company's market capitalization of $42 billion, against $19.5 billion in revenue, reflects a premium multiple that investors assign to businesses with durable category positions. Kimberly-Clark has paid dividends continuously for more than 50 years. That consistency matters to a specific class of investor, and that investor base provides a stable ownership structure that gives management the freedom to invest in long-cycle manufacturing improvements rather than optimizing for quarterly results.